FDA-approved as Victoza for type 2 diabetes in patients 10 and older, and as Saxenda for chronic weight management. Two products, two separate indications.
An approval for one condition is not an approval for everything a compound is marketed for. That distinction is where most confusion in this category comes from — a drug approved for one use is frequently sold for several others it was never evaluated for.
—Source
Checked against the public registry
This answer is generated from ClinicalTrials.gov records, counting
interventional human studies only. It is automated aggregation, not medical
advice, and no physician has reviewed it. See
how we count or open the
Liraglutide page
to check every trial yourself.